Why is weight status important in drug dosing of fat soluble drugs?

Why is weight status important in drug dosing of fat soluble drugs?

• A. Distribution of fat-soluble drugs increases in obese older adults due to higher fat-to-lean mass ratio
• B. Distribution of fat-soluble drugs decreases in adipose tissue
• C. Distribution is unaffected by weight status
• D. Increased renal clearance

Answer: (A)

Lipophilic (fat-soluble) drugs partition into adipose tissue, so changes in body fat directly change their distribution. In obese older adults, the fat-to-lean mass ratio is higher, providing a larger reservoir for these drugs. This increases the volume of distribution, which tends to lower the initial peak concentration after dosing and can prolong the drug’s half-life as it is released more slowly from fat stores. Because of this, weight status is important for dosing: you may need a larger loading dose to achieve therapeutic levels and may adjust maintenance dosing to avoid prolonged exposure or accumulation. The other statements don’t fit this pattern: fat-soluble drug distribution does not decrease in adipose tissue, and weight status does affect distribution. While obesity can influence renal clearance in some cases, the primary and most consistent issue with fat-soluble drugs is the increased distribution into expanded fat stores.

Lipophilic (fat-soluble) drugs partition into adipose tissue, so changes in body fat directly change their distribution. In obese older adults, the fat-to-lean mass ratio is higher, providing a larger reservoir for these drugs. This increases the volume of distribution, which tends to lower the initial peak concentration after dosing and can prolong the drug’s half-life as it is released more slowly from fat stores. Because of this, weight status is important for dosing: you may need a larger loading dose to achieve therapeutic levels and may adjust maintenance dosing to avoid prolonged exposure or accumulation.

The other statements don’t fit this pattern: fat-soluble drug distribution does not decrease in adipose tissue, and weight status does affect distribution. While obesity can influence renal clearance in some cases, the primary and most consistent issue with fat-soluble drugs is the increased distribution into expanded fat stores.